Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …

News
Pfizer Sandwich image

Pfizer Sandwich site sold to private consortium

August 3, 2012
Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …

News
Shire image

Shire posts strong quarter results

August 2, 2012
Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

News

Pfizer’s RA pill impresses in Phase III

August 1, 2012
Research and Development, Sales and Marketing FDA, JAK, Pfizer, RA

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …

News

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

News
Prevenar 13 image

Prevenar 13 rejected for UK vaccination programme

July 27, 2012
Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13

The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …

News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …

News
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …

Feature
Apps image

Apps not the way forward for trial recruitment

June 28, 2012
Medical Communications Pfizer, apps, digital, virtual trial

After Pfizer admitted defeat in the first ever ‘virtual trial’ earlier this year, it seems that we are not yet …

News
Eliquis image

FDA delays Eliquis approval

June 26, 2012
Sales and Marketing BMS, Eliquis, FDA, Pfizer, Xarelto

The FDA has asked Pfizer and Bristol-Myers Squibb for more information about its key blood thinner Eliquis. The US regulator …

News

MPs find NHS bodies still blocking treatments

June 25, 2012
Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra

The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …

News
Pfizer image

Pfizer Gaucher drug rejected by CHMP

June 25, 2012
Sales and Marketing Elelyso, FDA, Gaucher, Pfizer, Shire, Vpriv

A European committee has refused marketing authorisation for Pfizer’s Gaucher disease drug Elelyso, as a competitor drug has exclusivity to …

News
Pfizer image

Pfizer vows to learn from virtual trial failure

June 22, 2012
Medical Communications Pfizer, REMOTE, Think science now, digital

Several months after Pfizer failed to recruit patients to its first ever virtual trial, the firm said it was looking …

News
Pfizer image

FDA holds up Pfizer’s rare disease drug tafamidis

June 19, 2012
Research and Development, Sales and Marketing FDA, Pfizer, rare disease, tafamidis

The FDA has sent Pfizer a Complete Response Letter about its rare disease drug tafamidis meglumine. The US regulator is …

News
Pfizer's website

Pfizer launches ‘Campaign Against Migraine’ website

June 18, 2012
Medical Communications Botox, Pfizer, Relpax, digital, migraine

Pfizer has launched a new website called ‘Campaign Against Migraine’ to help migraine sufferers in the US learn more about …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026